OverviewChartNewsTraderScreen

UniCredit Call 120 AZN 19.03.2025/  DE000HD43JX7  /

EUWAX
2024-11-13  9:39:40 PM Chg.+0.020 Bid9:59:12 PM Ask9:59:12 PM Underlying Strike price Expiration date Option type
0.170EUR +13.33% 0.160
Bid Size: 10,000		 0.200
Ask Size: 10,000		 Astrazeneca PLC ORD ... 120.00 - 2025-03-19 Call
TeleTrader 11-12 AstraZeneca's revenue in Q3 rises 21% to $13.5B
GlobeNewswire 08-12 Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune...
GlobeNewswire 08-08 Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets...
GlobeNewswire 08-06 Cellectis Provides Financial Results for the Second Quarter 2024
TeleTrader 07-25 AstraZeneca's Q2 revenue up by 13% to $12.94B
GlobeNewswire 07-15 AstraZeneca Closes Acquisition of Amolyt Pharma
GlobeNewswire 06-26 As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Co...
GlobeNewswire 06-18 Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to...
GlobeNewswire 06-18 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 06-13 Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics
GlobeNewswire 05-28 Cellectis Reports Financial Results for First Quarter 2024
TeleTrader 05-21 AstraZeneca to deliver $80B total revenue by 2030
TeleTrader 05-20 AstraZeneca to build $1.5B plant in Singapore
GlobeNewswire 05-08 Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire 05-06 FibroGen Reports First Quarter 2024 Financial Results
GlobeNewswire 05-06 Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire 04-29 Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
TeleTrader 04-25 Europe opens mostly down after corporate earnings
TeleTrader 04-25 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 03-28 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
TeleTrader 03-19 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 03-18 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 03-14 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 03-14 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
GlobeNewswire 02-28 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates